Nir Arbel, PhD
Operating Partner, Esco Ventures
CEO, Carmentix Pte Ltd
Nir has extensive experience in multiple startup companies developing therapeutics and diagnostics. Until recently Nir was Head of R&D for Acumen research laboratories involved in a clinically relevant diagnostic tool for Sepsis. Nir previously served as a project manager at VIDAC-Pharma, a startup company developing novel small molecules for the treatment of cancer based on a unique mode of action.
Throughout his work, Nir led the R&D of pre-clinical phase of development of API for the treatment of non-melanoma skin cancer. He obtained his PhD degree from Ben-Gurion University in Israel.